Health Condition 1: K641- Second degree hemorrhoids
Conditions
Interventions
Intervention1: Habb-e- Anjeer: 2 Pills (1 gm each) Twice a day With water after meal for 6 weeks
Control Intervention1: Nil: Nil
Control Intervention2: nil: nil
Sponsors
Central Council for Research in Unani Medicine CCRUM New Delhi
Eligibility
Inclusion criteria
Inclusion criteria: Patients of Internal Haemorrhoids presenting with any of the following symptoms: 1. Mucoid Anal and Perianal Discharge 2. Pruritus Ani (Hikka al-Maq ad) 3. Rectal and Anal Pain (Waja-al-Maq ad) 4. Rectal Bleeding
Exclusion criteria
Exclusion criteria: 1. Third & Fourth Degree Internal Haemorrhoids, 2. Severe Anaemia (Hb less than 8 g/dL) 3. Known cases of fistula and fissure in anal canal 4. Patient with rectal prolapse, polyp and abdominal mass. 5. Known cases of IBD & Bowel carcinoma. 6. Immuno-compromised clinical conditions such as diabetes mellitus type 2, HIV/AIDS, cancer, etc. 7. Known cases of other clinically significant co-morbid conditions (severe hepatic, renal, cardiovascular disorders, etc.) 8. Pregnancy and lactation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The efficacy of the study drug in the treatment of Bawaseer (Haemorrhoids) will be assessed on the basis of Haemorrhoidal Disease Symptom Score i.e., Pain, Itching, Bleeding, soiling, and prolapse as proposed by Nystr m et al (2010).Timepoint: At baseline and every two weeks. (i.e., 0, 2nd, 4th, and 6th week) | — |
Secondary
| Measure | Time frame |
|---|---|
| Haematological & biochemical assessment for safety assessment i.e. CBC, LFT, KFT, Urine Routine & microscopic examination.Timepoint: At baseline, first follow up and the end of treatment. (i.e., o, 2nd and 6th week) | — |
Countries
India
Contacts
Public ContactDr Pradeep Kumar
Central Council for Research in Unani Medicine (CCRUM)
Outcome results
None listed